North America Biobanks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)

Name: North America Biobanks Market
SKU: Biotechnology
Rating: 4.1 (94 reviews)

The biobanks market in North America is expected to grow from US$ 875.19 million in 2021 to US$ 1,386.56 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

Regenerative therapies help induce the regeneration of cells, tissues, and organs and restore their functions. Each year, the increasing number of regenerative medicine applications for human clinical trials is submitted to the Food and Drug Administration (FDA). As per the Alliance for Regenerative Medicine, in the Q3 of 2019, 1,052 clinical trials utilizing regenerative medicine were underway globally. Also, 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements in regenerative medicines to provide effective solutions for chronic conditions drive market growth. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in developing regenerative medicine technologies and has a huge pipeline of products for various conditions, such as diabetes, Hemophilia A, and hyperthyroidism. Biobank is a major asset in the field of regenerative medicine as it provides materials for research, development, and therapy. Furthermore, associating each biospecimen (in part or in whole) with relevant patient demographics and medical data can be a source of big data that leads to improved patient outcomes and new therapeutic approaches developments. As the foundation for a successful regenerative medicine and tissue engineering program, investing in biobanking can yield considerable cost recoveries. Thus, the rising adoption of regenerative medicines propels the growth of the biobanks market.

The COVID-19 pandemic was an once-in-a-lifetime occurrence that had far-reaching health-care, economic, and societal consequences around the world. The health-care system in North America faced an immediate issue in estimating the demographics of COVID-19's impact. In the absence of precise data, a lockdown was enforced early, putting the health-care system under even more strain to care for non-COVID-19 patients who needed immediate attention. The lockdown had an immediate impact on logistics and supply lines, which had an impact on health-care delivery in the region. In the early stages of COVID-19, biobanking activities in Canada were considered a non-essential health care service, but as necessary research operations began, COVID-19–related studies were permitted and launched. Biobanking became a necessary service as a result of this development, allowing for faster COVID-19 research and the continuation of critical research operations. During the epidemic, navigating the scarce and frequently competing health-care supply chains was critical for continuous operational demands. biobanks have had to purchase extra personal protective equipment (PPE) to safeguard their personnel from COVID-19, and even employees have had to be regularly checked for suspected COVID-19 symptoms. Biobanks had to communicate and search globally for the materials they required to quickly collect and store specimens. Biobanks are critical in collecting and preserving biosamples such as plasma, serum, DNA and RNA, clinical data, and genomic data due to the large number of clinical trials related to COVID-19.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America biobanks market. The North America biobanks market is expected to grow at a good CAGR during the forecast period.

North America Biobanks market Revenue and Forecast to 2028 (US$ Million)

North America Biobanks Market Segmentation

North America Biobanks Market – By Product and Service

Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
Service
- Storage Services
- Processing Services
- Transport Services
- Supply Services
Software

North America Biobanks Market – By Sample

Blood Products
Human Tissues
Cell Lines
Others

North America Biobanks Market – By Application

Regenerative Medicine
Life Science Research
Clinical Research

North America Biobanks Market – By Country

US
Canada
Mexico

North America Biobanks Market – Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Biobanks Market – By Product and Service

1.3.2 North America Biobanks Market – By Sample

1.3.3 North America Biobanks Market – By Application

1.3.4 North America Biobanks Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Biobanks Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. North America Biobanks Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Burgeoning Funding and Genomic Research Activities for Studying Diseases

5.1.2 Surging Adoption of Regenerative Medicines

5.2 Market Restraints

5.2.1 Higher Cost of Automation

5.3 Future Trends

5.3.1 Virtual Biobanks

5.4 Impact Analysis

6. North America Biobanks Market Analysis

6.1 North America Biobanks Market Revenue Forecast and Analysis

6.2 North America Biobanks Market, By Geography - Forecast and Analysis

7. North America Biobanks Market – by Product and Service

7.1 Overview

7.2 North America Biobanks Market, By Product and Service, 2021 & 2028 (%)

7.3 Equipment

7.3.1 Overview

7.3.2 Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

7.3.2.1 Storage Equipment

7.3.2.1.1 Overview

7.3.2.1.2 Storage Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Sample Analysis Equipment

7.3.2.2.1 Overview

7.3.2.2.2 Sample Analysis Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Sample Processing Equipment

7.3.2.3.1 Overview

7.3.2.3.2 Sample Processing Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Sample Transport Equipment

7.3.2.4.1 Overview

7.3.2.4.2 Sample Transport Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.4 Consumables

7.4.1 Overview

7.4.2 Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

7.4.2.1 Storage Consumables

7.4.2.1.1 Overview

7.4.2.1.2 Storage Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Analysis Consumables

7.4.2.2.1 Overview

7.4.2.2.2 Analysis Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Processing Consumables

7.4.2.3.1 Overview

7.4.2.3.2 Processing Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Collection Consumables

7.4.2.4.1 Overview

7.4.2.4.2 Collection Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.5 Services

7.5.1 Overview

7.5.2 Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

7.5.2.1 Storage Services

7.5.2.1.1 Overview

7.5.2.1.2 Storage Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Processing Services

7.5.2.2.1 Overview

7.5.2.2.2 Processing Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Transport Services

7.5.2.3.1 Overview

7.5.2.3.2 Transport Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.5.2.4 Supply Services

7.5.2.4.1 Overview

7.5.2.4.2 Supply Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

8. North America Biobanks Market – By Sample

8.1 Overview

8.2 North America Biobanks Market Share by Application - 2021 & 2028 (%)

8.3 Blood Products

8.3.1 Overview

8.3.2 Blood Products: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

8.4 Human Tissues

8.4.1 Overview

8.4.2 Human Tissues: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

8.5 Cell Lines

8.5.1 Overview

8.5.2 Cell Lines: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

9. North America Biobanks Market – By Application

9.1 Overview

9.2 North America Biobanks Market Share by Application - 2021 & 2028 (%)

9.3 Regenerative Medicine

9.3.1 Overview

9.3.2 Regenerative Medicine: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

9.4 Life Science Research

9.4.1 Overview

9.4.2 Life Science Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

9.5 Clinical Research

9.5.1 Overview

9.5.2 Clinical Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)

10. North America Biobanks Market – Country Analysis

10.1 Overview

10.1.1 North America: Biobanks Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 US: Biobanks Market, by Product and Service, 2019–2028 (USD Million)

10.1.1.1.3.1 US: Biobanks Market, by Equipment, 2019–2028 (USD Million)

10.1.1.1.3.2 US: Biobanks Market, by Consumables, 2019–2028 (USD Million)

10.1.1.1.3.3 US: Biobanks Market, by Services, 2019–2028 (USD Million)

10.1.1.1.4 US: Biobanks Market, by Sample, 2019–2028 (USD Million)

10.1.1.1.5 US: Biobanks Market, by Application, 2019–2028 (USD Million)

10.1.1.2 Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Canada: Biobanks Market, by Product and Service - 2019–2028 (USD Million)

10.1.1.2.3.1 Canada: Biobanks Market, by Equipment, 2019–2028 (USD Million)

10.1.1.2.3.2 Canada: Biobanks Market, by Consumables, 2019–2028 (USD Million)

10.1.1.2.3.3 Canada: Biobanks Market, by Services, 2019–2028 (USD Million)

10.1.1.2.4 Canada: Biobanks Market, by Sample, 2019–2028 (USD Million)

10.1.1.2.5 Canada: Biobanks Market, by Application, 2019–2028 (USD Million)

10.1.1.3 Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 Mexico: Biobanks Market, by Product and Service, 2019–2028 (USD Million)

10.1.1.3.3.1 Mexico: Biobanks Market, by Equipment, 2019–2028 (USD Million)

10.1.1.3.3.2 Mexico: Biobanks Market, by Consumables, 2019–2028 (USD Million)

10.1.1.3.3.3 Mexico: Biobanks Market, by Services, 2019–2028 (USD Million)

10.1.1.3.4 Mexico: Biobanks Market, by Sample, 2019–2028 (USD Million)

10.1.1.3.5 Mexico: Biobanks Market, by Application, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Biobanks Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. North America Biobanks Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Tecan Trading AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Hamilton Company

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Avantor, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 MICRONICS JAPAN CO., LTD.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BD

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Taylor-Wharton

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Brooks Automation, Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Promega Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 SciSafe Inc.

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 2. US Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)

Table 3. US Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)

Table 4. US Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)

Table 5. US Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)

Table 6. US Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)

Table 17. Mexico Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)

Table 18. Mexico Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Organic Developments Done By Companies

Table 20. Inorganic Developments Done by Companies

Table 21. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Biobanks Market Segmentation

Figure 2. North America Biobanks Market, By Country

Figure 3. North America Biobanks Market Overview

Figure 4. Equipment Segment Held Largest Share of Product and Service Segment in North America Biobanks Market

Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. North America Biobanks Market, Industry Landscape

Figure 7. North America: PEST Analysis

Figure 8. Experts Opinion

Figure 9. North America Biobanks Market – By Country Forecast and Analysis 2021 - 2028

Figure 10. North America Biobanks Market, by Product and Service, 2021 & 2028 (%)

Figure 11. Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Storage Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Sample Analysis Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Sample Processing Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Sample Transport Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Storage Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Analysis Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Processing Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Collection Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Storage Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Processing Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Transport Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Supply Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. North America Biobanks Market Share by Application - 2021 & 2028 (%)

Figure 28. Blood Products: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Human Tissues: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Cell Lines: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Others: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. North America Biobanks Market Share by Application - 2021 & 2028 (%)

Figure 33. Regenerative Medicine: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34. Life Science Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35. Clinical Research: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. North America: Biobanks Market, by Key Country – Revenue (2021) (USD Million)

Figure 37. North America: Biobanks Market, by Country, 2021 & 2028 (%)

Figure 38. US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America biobanks market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America biobanks market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the biobanks market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1500

Site License

$4000

$2000

Enterprise License

$5000

$2500

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription